Forte Biosciences Q4 EPS $(1.45) Misses $(1.06) Estimate

Forte Biosciences (NASDAQ: FBRX) reported a Q4 loss of $(1.45) per share, missing the analyst consensus estimate of $(1.06) by 37.05%. This represents a 22.88% increase in losses compared to $(1.18) per share in the same quarter last year.